236 related articles for article (PubMed ID: 27036136)
1. Extracellular Visfatin-Promoted Malignant Behavior in Breast Cancer Is Mediated Through c-Abl and STAT3 Activation.
Hung AC; Lo S; Hou MF; Lee YC; Tsai CH; Chen YY; Liu W; Su YH; Lo YH; Wang CH; Wu SC; Hsieh YC; Hu SC; Tai MH; Wang YM; Yuan SS
Clin Cancer Res; 2016 Sep; 22(17):4478-90. PubMed ID: 27036136
[TBL] [Abstract][Full Text] [Related]
2. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
[TBL] [Abstract][Full Text] [Related]
3. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
Wang J; Xu J; Xing G
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
[TBL] [Abstract][Full Text] [Related]
4. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
5. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
Li JT; Jia LT; Liu NN; Zhu XS; Liu QQ; Wang XL; Yu F; Liu YL; Yang AG; Gao CF
Oncotarget; 2015 Oct; 6(31):30818-30. PubMed ID: 26360780
[TBL] [Abstract][Full Text] [Related]
7. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
[TBL] [Abstract][Full Text] [Related]
8. High visfatin expression in breast cancer tissue is associated with poor survival.
Lee YC; Yang YH; Su JH; Chang HL; Hou MF; Yuan SS
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1892-901. PubMed ID: 21784959
[TBL] [Abstract][Full Text] [Related]
9. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
Wang J; Rouse C; Jasper JS; Pendergast AM
Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum visfatin levels and prognosis of breast cancer among Chinese women.
Li XY; Tang SH; Zhou XC; Ye YH; Xu XQ; Li RZ
Peptides; 2014 Jan; 51():86-90. PubMed ID: 24269296
[TBL] [Abstract][Full Text] [Related]
11. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
12. Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis.
Kim JY; Bae YH; Bae MK; Kim SR; Park HJ; Wee HJ; Bae SK
Biochim Biophys Acta; 2009 Nov; 1793(11):1759-67. PubMed ID: 19751774
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
[TBL] [Abstract][Full Text] [Related]
14. Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases.
Wang G; Tian W; Liu Y; Ju Y; Shen Y; Zhao S; Zhang B; Li Y
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):548-554. PubMed ID: 27224551
[TBL] [Abstract][Full Text] [Related]
15. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.
Matzke-Ogi A; Jannasch K; Shatirishvili M; Fuchs B; Chiblak S; Morton J; Tawk B; Lindner T; Sansom O; Alves F; Warth A; Schwager C; Mier W; Kleeff J; Ponta H; Abdollahi A; Orian-Rousseau V
Gastroenterology; 2016 Feb; 150(2):513-25.e10. PubMed ID: 26597578
[TBL] [Abstract][Full Text] [Related]
17. FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression.
Zhao X; Xu F; Dominguez NP; Xiong Y; Xiong Z; Peng H; Shay C; Teng Y
Mol Carcinog; 2018 Nov; 57(11):1616-1625. PubMed ID: 30074276
[TBL] [Abstract][Full Text] [Related]
18. 15-Keto prostaglandin E
Lee EJ; Kim SJ; Hahn YI; Yoon HJ; Han B; Kim K; Lee S; Kim KP; Suh YG; Na HK; Surh YJ
Redox Biol; 2019 May; 23():101175. PubMed ID: 31129031
[TBL] [Abstract][Full Text] [Related]
19. Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer.
Park HJ; Kim SR; Kim SS; Wee HJ; Bae MK; Ryu MH; Bae SK
Oncotarget; 2014 Jul; 5(13):5087-99. PubMed ID: 24970818
[TBL] [Abstract][Full Text] [Related]
20. Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2.
Liu T; Miao Z; Jiang J; Yuan S; Fang W; Li B; Chen Y
Int J Mol Sci; 2015 May; 16(5):11439-51. PubMed ID: 25993304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
